More topics

COPD Inhaled Medications

Last updated on June 24, 2019
Personalized education in 30-60 minutes in your office at a time that is convenient for you. This Group Learning program has been certified by the College of Family Physicians of Canada for up to 2.0 Mainpro+ credits. 

Learning Objective

Participants will be able to apply evidence about inhaled medications and devices to confidently initiate, re-evaluate
and discontinue medications for their COPD patients.

During the academic detailing session, participants will have the opportunity to:

  1. Discuss the effect of intensifying inhaled therapies on health-related quality of life, the risk of exacerbations
    and the risk of death (i.e., when progressing to double or triple therapy);
  2. Discuss relevant clinical considerations when prescribing and monitoring patients receiving inhaled therapies;
  3. Compare efficacy, safety, dosing and costs of inhaled therapies; and
  4. Describe the advantages and disadvantages of various medication inhalation devices.

Availability

When: Until September 14, 2018
Where: Your office at your convenience, or via individual Web session
How: Email pad@gov.bc.ca or Phone 604 660-1978

Resources

For more information about the PAD service, visit PAD Frequently Asked Questions.